Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Trends Cancer. 2021 Apr 14;7(8):714–730. doi: 10.1016/j.trecan.2021.03.001

Figure 4. Modulation of anti-tumor immunity by biguanides.

Figure 4.

In the tumor immune microenvironment, biguanides can derepress the functionality of cytotoxic CD8+ T cells. In addition, they can inhibit the recruitment or activities of immunosuppressive populations including PMN-MDSCs, M-MDSCs, TAMs, and Tregs.